Affimed Price To Sales Ratio vs Ev To Sales Analysis

AFMD Stock

USD 2.64 0.08 2.94%

Affimed NV financial indicator trend analysis is way more than just evaluating Affimed NV prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Affimed NV is a good investment. Please check the relationship between Affimed NV Price To Sales Ratio and its Ev To Sales accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.

Price To Sales Ratio vs Ev To Sales

Price To Sales Ratio vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Affimed NV Price To Sales Ratio account and Ev To Sales. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Affimed NV's Price To Sales Ratio and Ev To Sales is 0.98. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Affimed NV, assuming nothing else is changed. The correlation between historical values of Affimed NV's Price To Sales Ratio and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Affimed NV are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Price To Sales Ratio i.e., Affimed NV's Price To Sales Ratio and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Affimed NV stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Affimed NV sales, a figure that is much harder to manipulate than other Affimed NV multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Affimed NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Affimed NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.At present, Affimed NV's Enterprise Value is projected to decrease significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Interest Expense	712K	1.6M	1.8M	1.8M
Depreciation And Amortization	1.4M	2.8M	1.7M	1.8M

Interest Expense Depreciation And Amortization

Affimed NV fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock
Total Assets		-0.47	0.78	0.9	0.89	0.35	0.37	0.75	-0.93	-0.68	0.88	0.96	0.74	-0.63	1.0	0.61	0.83	0.74	-0.46	0.8	0.77	0.15	0.31	1.0	0.56	0.81
Short Long Term Debt Total	-0.47		-0.32	-0.46	-0.59	-0.32	-0.15	-0.33	0.68	0.36	-0.38	-0.42	-0.27	0.77	-0.48	-0.3	-0.47	-0.29	0.65	-0.37	-0.44	0.3	-0.14	-0.48	-0.05	-0.4
Other Current Liab	0.78	-0.32		0.77	0.64	0.29	0.75	0.52	-0.58	-0.87	0.82	0.6	0.79	-0.44	0.74	0.83	0.89	0.9	-0.3	0.71	0.86	0.23	0.72	0.75	0.46	0.9
Total Current Liabilities	0.9	-0.46	0.77		0.65	0.61	0.33	0.91	-0.82	-0.57	0.76	0.83	0.9	-0.48	0.87	0.56	0.77	0.63	-0.19	0.56	0.68	0.46	0.28	0.87	0.75	0.69
Total Stockholder Equity	0.89	-0.59	0.64	0.65		0.06	0.34	0.5	-0.89	-0.66	0.79	0.86	0.51	-0.84	0.9	0.57	0.77	0.68	-0.8	0.83	0.75	-0.32	0.3	0.9	0.3	0.77
Other Liab	0.35	-0.32	0.29	0.61	0.06		0.08	0.61	-0.34	-0.17	0.24	0.3	0.46	-0.19	0.34	0.05	0.37	0.17	0.25	0.05	0.23	0.61	0.06	0.33	0.28	0.23
Property Plant And Equipment Net	0.37	-0.15	0.75	0.33	0.34	0.08		-0.01	-0.12	-0.9	0.63	0.1	0.42	-0.32	0.32	0.9	0.78	0.87	-0.26	0.56	0.8	0.01	1.0	0.35	-0.02	0.82
Current Deferred Revenue	0.75	-0.33	0.52	0.91	0.5	0.61	-0.01		-0.73	-0.22	0.5	0.77	0.85	-0.37	0.73	0.25	0.5	0.29	-0.08	0.26	0.38	0.49	-0.06	0.72	0.87	0.37
Net Debt	-0.93	0.68	-0.58	-0.82	-0.89	-0.34	-0.12	-0.73		0.48	-0.74	-0.95	-0.6	0.71	-0.94	-0.39	-0.67	-0.53	0.56	-0.71	-0.61	0.0	-0.07	-0.93	-0.49	-0.63
Retained Earnings	-0.68	0.36	-0.87	-0.57	-0.66	-0.17	-0.9	-0.22	0.48		-0.86	-0.46	-0.55	0.54	-0.65	-0.91	-0.94	-0.99	0.45	-0.83	-0.96	0.02	-0.88	-0.67	-0.1	-0.98
Accounts Payable	0.88	-0.38	0.82	0.76	0.79	0.24	0.63	0.5	-0.74	-0.86		0.76	0.67	-0.54	0.85	0.78	0.89	0.89	-0.42	0.93	0.88	0.1	0.58	0.87	0.34	0.91
Cash	0.96	-0.42	0.6	0.83	0.86	0.3	0.1	0.77	-0.95	-0.46	0.76		0.63	-0.56	0.97	0.38	0.65	0.54	-0.41	0.73	0.58	0.14	0.04	0.96	0.58	0.63
Non Current Assets Total	0.74	-0.27	0.79	0.9	0.51	0.46	0.42	0.85	-0.6	-0.55	0.67	0.63		-0.37	0.68	0.6	0.72	0.58	-0.14	0.41	0.63	0.44	0.38	0.69	0.84	0.62
Long Term Debt	-0.63	0.77	-0.44	-0.48	-0.84	-0.19	-0.32	-0.37	0.71	0.54	-0.54	-0.56	-0.37		-0.64	-0.45	-0.67	-0.49	0.9	-0.56	-0.65	0.51	-0.31	-0.64	-0.08	-0.61
Cash And Short Term Investments	1.0	-0.48	0.74	0.87	0.9	0.34	0.32	0.73	-0.94	-0.65	0.85	0.97	0.68	-0.64		0.57	0.8	0.72	-0.48	0.81	0.75	0.12	0.27	1.0	0.52	0.79
Net Receivables	0.61	-0.3	0.83	0.56	0.57	0.05	0.9	0.25	-0.39	-0.91	0.78	0.38	0.6	-0.45	0.57		0.86	0.91	-0.4	0.66	0.9	0.02	0.88	0.59	0.25	0.89
Common Stock Total Equity	0.83	-0.47	0.89	0.77	0.77	0.37	0.78	0.5	-0.67	-0.94	0.89	0.65	0.72	-0.67	0.8	0.86		0.94	-0.49	0.81	0.97	0.07	0.75	0.82	0.31	0.98
Common Stock Shares Outstanding	0.74	-0.29	0.9	0.63	0.68	0.17	0.87	0.29	-0.53	-0.99	0.89	0.54	0.58	-0.49	0.72	0.91	0.94		-0.39	0.86	0.96	0.07	0.84	0.73	0.18	0.99
Non Current Liabilities Total	-0.46	0.65	-0.3	-0.19	-0.8	0.25	-0.26	-0.08	0.56	0.45	-0.42	-0.41	-0.14	0.9	-0.48	-0.4	-0.49	-0.39		-0.54	-0.53	0.78	-0.25	-0.48	0.07	-0.49
Inventory	0.8	-0.37	0.71	0.56	0.83	0.05	0.56	0.26	-0.71	-0.83	0.93	0.73	0.41	-0.56	0.81	0.66	0.81	0.86	-0.54		0.83	-0.13	0.52	0.82	0.09	0.88
Other Stockholder Equity	0.77	-0.44	0.86	0.68	0.75	0.23	0.8	0.38	-0.61	-0.96	0.88	0.58	0.63	-0.65	0.75	0.9	0.97	0.96	-0.53	0.83		-0.02	0.77	0.76	0.23	0.97
Total Liab	0.15	0.3	0.23	0.46	-0.32	0.61	0.01	0.49	0.0	0.02	0.1	0.14	0.44	0.51	0.12	0.02	0.07	0.07	0.78	-0.13	-0.02		-0.01	0.11	0.52	0.01
Property Plant And Equipment Gross	0.31	-0.14	0.72	0.28	0.3	0.06	1.0	-0.06	-0.07	-0.88	0.58	0.04	0.38	-0.31	0.27	0.88	0.75	0.84	-0.25	0.52	0.77	-0.01		0.29	-0.07	0.79
Total Current Assets	1.0	-0.48	0.75	0.87	0.9	0.33	0.35	0.72	-0.93	-0.67	0.87	0.96	0.69	-0.64	1.0	0.59	0.82	0.73	-0.48	0.82	0.76	0.11	0.29		0.51	0.8
Intangible Assets	0.56	-0.05	0.46	0.75	0.3	0.28	-0.02	0.87	-0.49	-0.1	0.34	0.58	0.84	-0.08	0.52	0.25	0.31	0.18	0.07	0.09	0.23	0.52	-0.07	0.51		0.22
Common Stock	0.81	-0.4	0.9	0.69	0.77	0.23	0.82	0.37	-0.63	-0.98	0.91	0.63	0.62	-0.61	0.79	0.89	0.98	0.99	-0.49	0.88	0.97	0.01	0.79	0.8	0.22

Click cells to compare fundamentals

Affimed NV Account Relationship Matchups

Affimed NV fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	112.4M	175.7M	225.1M	200.5M	97.2M	105.8M
Short Long Term Debt Total	3.2M	1.3M	18.7M	18.2M	19.4M	11.4M
Other Current Liab	24.3M	517K	58.5M	46.2M	53.1M	55.8M
Total Current Liabilities	35.2M	67.0M	64.5M	34.7M	25.9M	28.4M
Total Stockholder Equity	38.7M	72.0M	136.0M	152.9M	57.8M	45.3M
Other Liab	37.5M	38.0M	36.0M	7.2M	8.3M	15.7M
Property Plant And Equipment Net	3.1M	3.2M	4.8M	4.4M	12.9M	13.6M
Current Deferred Revenue	21.4M	55.0M	44.4M	9.2M	619K	588.1K
Net Debt	(92.0M)	(145.6M)	(178.9M)	(172.1M)	(19.2M)	(20.1M)
Retained Earnings	(234.5M)	(275.9M)	(333.4M)	(430.2M)	(536.1M)	(509.3M)
Accounts Payable	10.7M	11.4M	18.9M	19.1M	18.9M	10.3M
Cash	95.2M	146.9M	197.6M	190.3M	38.5M	36.6M
Non Current Assets Total	6.4M	24.9M	18.7M	4.4M	13.0M	7.3M
Long Term Debt	278K	231K	17.1M	11.7M	6.3M	6.0M
Cash And Short Term Investments	104.1M	146.9M	197.6M	190.3M	72.9M	94.5M
Net Receivables	1.5M	2.4M	4.8M	2.7M	5.3M	5.6M
Common Stock Total Equity	468K	624K	762K	983K	1.1M	1.2M
Common Stock Shares Outstanding	6.4M	8.3M	12.0M	14.2M	14.9M	15.7M
Liabilities And Stockholders Equity	112.4M	175.7M	225.1M	200.5M	97.2M	105.8M
Non Current Liabilities Total	38.5M	36.7M	24.6M	12.9M	13.4M	23.3M
Inventory	296K	246K	421K	628K	463K	315.3K
Other Stockholder Equity	273.2M	346.9M	468.1M	469.3M	539.8M	566.7M
Total Liab	73.7M	103.7M	89.2M	47.6M	39.4M	60.4M
Property Plant And Equipment Gross	3.1M	3.2M	4.8M	4.4M	16.0M	16.8M
Total Current Assets	105.9M	150.8M	206.4M	196.1M	84.2M	98.5M
Accumulated Other Comprehensive Income	272.4M	346.9M	468.1M	581.6M	592.4M	622.1M
Intangible Assets	137K	1.7M	1.6M	58K	25K	23.8K
Common Stock	762K	983K	1.2M	1.5M	1.5M	1.6M
Property Plant Equipment	1.4M	3.1M	3.2M	4.8M	5.5M	5.8M
Net Tangible Assets	40.1M	38.5M	70.3M	134.3M	154.5M	162.2M
Short Long Term Debt	2.1M	92K	580K	5.9M	5.8M	8.3M
Short Term Debt	2.6M	584K	1.3M	6.3M	6.4M	3.4M
Capital Lease Obligations	804K	974K	1.1M	572K	7.2M	7.6M
Other Current Assets	8.9M	1.3M	3.5M	(2.7M)	5.5M	5.8M
Net Invested Capital	41.1M	72.3M	153.6M	170.5M	70.0M	92.9M
Net Working Capital	70.7M	83.8M	141.8M	161.4M	58.3M	98.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:

How To Invest In Affimed

Details

Is Affimed Stock a good investment?

Details

What is Affimed NV's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.

You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.80)

Revenue Per Share

0.493

Quarterly Revenue Growth

(0.90)

Return On Assets

(0.49)

Return On Equity

(1.24)

The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Affimed Price To Sales Ratio vs Ev To Sales Analysis

Price To Sales Ratio vs Ev To Sales

Price To Sales Ratio vs Ev To Sales Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Ev To Sales

Affimed NV fundamental ratios Correlations

Affimed NV Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Affimed NV fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.98	Common Stock Total Equity

Common Stock Shares Outstanding	- 0.99	Retained Earnings
Common Stock	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.96	Retained Earnings
Cash	- 0.95	Net Debt
Common Stock Total Equity	- 0.94	Retained Earnings
Cash And Short Term Investments	- 0.94	Net Debt